Featured
Kohler Wisconsin Redefines Wellness Retreats with Integrated Design
Clinic Moves Sep 26, 2026
Trial Briefs Sep 25, 2026
Vaccine News Sep 24, 2026
Kohler Wisconsin redefines wellness retreats with integrated design, blending movement, recovery, and architecture into a...
FDA reviews two novel ADHD drug candidates in late-stage development, offering new approaches to treatment.
Zorevunersen dravet patients showed adaptive gains over two years, surpassing standard antiseizure therapy in a...
Read our latest Drug Approvals articles.
Doctors reject federal vaccine changes lacking scientific backing as top medical groups like AAP and...
Vonoprazan significantly reduces nighttime reflux symptoms in patients with NERD, offering a promising new treatment...
GammaTile slows brain tumor regrowth in glioblastoma patients with promising results from the GESTALT trial...
Kohler Wisconsin redefines wellness retreats with integrated design, blending movement, recovery, and architecture into a cohesive experience.
Kohler Wisconsin redefines wellness retreats with integrated design, blending movement, recovery, and architecture into a cohesive experience.
Standard physical tests often fail to diagnose chronic pelvic pain effectively. Learn how brain processing and inflammation play a larger...
Scientists suggest boosting glutathione may slow age-related cellular decline, offering one of the most promising approaches to support long-term health.
Family physicians weigh multiple factors when deciding whether to refer a patient for a hearing assessment, including symptoms and access...
Tirzepatide and semaglutide have similar asthma risks in adults with type 2 diabetes and asthma.
FDA reviews two novel ADHD drug candidates in late-stage development, offering new approaches to treatment.
Doctors reject federal vaccine changes lacking scientific backing as top medical groups like AAP and ACOG defend evidence-based immunization schedules.
Effective strategies for managing challenging patient relationships, focusing on cases where patients reject care or question competence.
The FIB-4 index celebrates 20 years as a non‑invasive tool for spotting advanced liver fibrosis in MASLD, MASH, hepatitis C...
New ATA guidelines for thyroid disease in pregnancy and preconception provide expert updates on testing, hypothyroidism, and iodine intake for...